Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study

Aún no traducido Aún no traducido
Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2008
Cargando información sobre las referencias
To assess the clinical efficacy and safety of certolizumab pegol as add-on therapy with stable-dose disease-modifying antirheumatic drugs (DMARDs) for achieving clinical remission in patients with moderate to low disease activity rheumatoid arthritis
Epistemonikos ID: 575d5868fc399406d6296e6455cf4c527261ac63
First added on: Nov 02, 2017